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Abstract
Background:  Germline and somatic inactivating mutations in the HRPT2 gene occur in the
inherited hyperparathyroidism-jaw tumor syndrome, in some cases of parathyroid cancer and in
some cases of familial hyperparathyroidism. HRPT2 encodes parafibromin. To identify parafibromin
interacting proteins we used the yeast two-hybrid system for screening a heart cDNA library with
parafibromin as the bait.
Results: Fourteen parafibromin interaction positive preys representing 10 independent clones
encoding actinin-2 were isolated. Parafibromin interacted with muscle alpha-actinins (actinin-2 and
actinin-3), but not with non-muscle alpha-actinins (actinin-1 and actinin-4). The parafibromin-actinin
interaction was verified by yeast two-hybrid, GST pull-down, and co-immunoprecipitation. Yeast
two-hybrid analysis revealed that the N-terminal region of parafibromin interacted with actinins. In
actin sedimentation assays parafibromin did not dissociate skeletal muscle actinins from actin
filaments, but interestingly, parafibromin could also bundle/cross-link actin filaments. Parafibromin
was predominantly nuclear in undifferentiated proliferating myoblasts (C2C12 cells), but in
differentiated C2C12 myotubes parafibromin co-localized with actinins in the cytoplasmic
compartment.
Conclusion: These data support a possible contribution of parafibromin outside the nucleus
through its interaction with actinins and actin bundling/cross-linking. These data also suggest that
actinins (and actin) participate in sequestering parafibromin in the cytoplasmic compartment.
Background
Parafibromin is encoded by the HRPT2 gene located on
chromosome 1q31[1] (OMIM# 145001 and 607393).
HRPT2 inactivating mutations in the germline occur in
the hyperparathyroidism-jaw tumor (HPT-JT) syndrome,
characterized by hyperparathyroidism (parathyroid ade-
noma or carcinoma) (90%), fibrous-ossifying jaw tumors
(30%), and bilateral renal cysts (10%) [1,2]. Germline
HRPT2 mutations have also been detected in some cases
of familial hyperparathyroidism [1,3,4], and biallelic
somatic inactivation of HRPT2 is common in parathyroid
tumor of HPT-JT and in sporadic parathyroid cancer [5-7].
Parafibromin has three possible nuclear localization sig-
nals; it is predominantly found in the nucleus [8-16] and
in the nucleolus [17]. The C-terminal part of parafibromin
(ORF = 531 amino acids) is homologous to yeast Cdc73p
(ORF = 393 amino acids), an RNA polymerase II accessory
protein [18]. Analogous to the presence of yeast Cdc73p
in the yeast Paf1 protein complex, parafibromin was
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found in the human and Drosophila PAF1 protein complex
[10,19-21]. Genetic interaction studies in Drosophila and
protein interaction studies in mammalian cells have
shown an interaction of parafibromin with β-catenin,
mediating a functional association between Wnt signaling
and the PAF1 complex [22].
The yeast two-hybrid system has been extensively used for
the identification and analysis of protein-protein interac-
tions [23,24]. To isolate parafibromin interacting proteins
we conducted a yeast two-hybrid library screen, and we
discovered an interaction between parafibromin and mus-
cle actinins.
Results
Parafibromin interacting proteins
To identify proteins that interact with parafibromin, a
yeast two-hybrid screen was performed with parafibromin
as the bait. Because no parafibromin interacting proteins
had been obtained by screening a human brain library
(data not shown) and because of high-level expression of
parafibromin in heart tissue [1], a human heart cDNA
library was screened. From 106 yeast transformants, 76
colonies grew in selection medium; 36 of 76 were positive
for the second reporter LacZ; upon retransformation 27 of
36 exhibited interaction with parafibromin. Sequencing
of the inserts from the 27 plasmids revealed cDNAs
encoding 6 different proteins (Table 1). There were 14
ACTN2 (actinin-2) sequences representing 10 independ-
ent clones, 5 FHL2  (four and a half LIM-domains 2)
sequences representing 3 independent clones, 3 DES
(desmin) sequences representing 3 independent clones,
and one sequence each of DMPK (dystrophia myotonica
protein kinase), CLTCL1 (clathrin heavy chain like-1) and
EEA1 (early endosome antigen 1). All sequences were in-
frame with the Gal4AD.
Since actinin-2, FHL2, and desmin were represented by
multiple independent library clones, they were analyzed
further for interaction of their full-length coding regions
with parafibromin. Full-length coding regions of all three
were also positive for interaction with GalDBD-parafibro-
min (Table 2). Actinin-2 and FHL2 each belong to fami-
lies of proteins; therefore, independent members of each
family were tested for interaction with parafibromin
(Table 2). Parafibromin selectively interacted with the
skeletal muscle actinins (actinin-2 and actinin-3), but did
not interact with the non-muscle actinins (actinin-1 and
actinin-4). Among the four FHL family members, parafi-
bromin only interacted with FHL2.
GST pull-down and co-immunoprecipitation of 
parafibromin interacting proteins
To verify the in vivo finding in yeast of parafibromin inter-
action with actinins, desmin and FHL2, GST pull-down
assays were performed (Figure 1). Protein extracts from
HEK293 cells expressing parafibromin-myc-his were
tested for binding to glutathione sepharose beads coupled
with GST alone, or with GST-actinin-2, GST-actinin-3,
GST-desmin, or GST-FHL2. Parafibromin was specifically
associated with GST-actinin-2, GST-actinin-3, but not
with GST alone, GST-desmin, or GST-FHL2 (Figure 1A
and Figure 1B). Desmin and FHL2 were not analyzed fur-
ther.
The interaction of parafibromin with actinins was further
characterized  in vivo by co-immunoprecipitation of
actinin-2 or actinin-3 from protein extracts of HEK293
cells transfected with parafibromin-myc-his or menin-
myc-his together with FLAG-tagged actinin-2 or actinin-3.
FLAG-actinin-2 and FLAG-actinin-3 co-precipitated with
parafibromin-myc-his but not with menin-myc-his (Fig-
ure 1C).
Interacting regions of parafibromin and actinin
N- or C-terminal deletion constructs of parafibromin or
actinin-3 were tested for interactions, in yeast two-hybrid
assays (Figure 2). All three C-terminal truncations of
parafibromin interacted with actinin-3, whereas the two
N-terminal truncations of parafibromin did not interact
with actinin-3. Each of the 10 yeast two-hybrid library
clones (actinin-2) that was isolated as a parafibromin
Table 1: Yeast Two-hybrid Library Screening
Gene
Name
Entrez
Gene ID
Description Number
of 
Colonies
Number of
Independent
Clones*
ACTN2 88 Skeletal muscle actinin, alpha-2 (actinin-2) 14 10
FHL2 2274 Four and a half LIM-domains 2 5 3
DES 1674 Desmin 3 3
DMPK 1760 Dystrophia myotonica protein kinase 3 1
CLTCL1 8218 Clathrin heavy chain like-1 1 1
EEA1 8411 Early endosome antigen 1 1 1
*ACTN2: 10 independent clones starting at amino acid (aa) 323, 327, 329, 333, 340, 360, 370, 377, 381 and 390 to the stop codon after aa 894; FHL2: 
3 independent full-length clones differed in the length of the 5' UTR (63 bp, 75 bp, and 150 bp); DES: 3 independent clones starting after aa 142, 115, 
and 203 to the stop codon after aa 468.Molecular Cancer 2008, 7:65 http://www.molecular-cancer.com/content/7/1/65
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interactor was N-terminally truncated at amino acids 323,
327, 329, 333, 340, 360, 370, 377, 381 and 390 (Table 1).
The N-terminus was located in the first spectrin repeat,
and each interacted strongly with parafibromin. Further
N-terminal truncations, deleting spectrin repeat 2 and 3 of
actinin-3, resulted in impaired interaction with parafibro-
min. C-terminal truncation of 150 amino acids of actinin-
3, deleting the 2 EF hand domains allowed interaction
with parafibromin; but further C-terminal deletion of
actinin-3, deleting spectrin repeats 3 and 4, prevented
interaction with parafibromin.
Actin filament bundling/cross-linking by actinin and 
parafibromin
Some actin-binding proteins organize actin filaments (F-
actin) into higher order structures by F-actin bundling
and/or F-actin cross-linking [25]. Actin bundling is the
arrangement of parallel or anti-parallel linear arrays of
actin filaments. Actin cross-linking causes the arrange-
ment of actin into a network of orthogonal arrays.
Actinins can bundle and cross-link actin filaments [26]. In
a low speed (10,000 g) actin sedimentation assay, F-actin
does not sediment in the pellet fraction unless it has been
induced to form higher order structure by the action of
bundling proteins or cross-linking proteins such as actinin
Verification of yeast two-hybrid interaction of parafibromin  with actinin Figure 1
Verification of yeast two-hybrid interaction of parafi-
bromin with actinin. (A) GST or GST-fusion proteins used 
for in vitro binding assay were analyzed by SDS-PAGE and 
stained with Coomassie Blue. On the left are shown molecu-
lar weights of the protein standards in kilodaltons. (B) GST 
pull-down assay: GST or GST-fusion proteins coupled to glu-
tathione sepharose beads were incubated with whole cell 
protein extracts from HEK293 cells transfected with plasmid 
expressing parafibromin-myc-his. The beads were washed 
thoroughly and the bound parafibromin was detected by 
western blotting (WB) with an anti-myc antibody. Input cor-
responds to 1/40th of the amount of protein extracts used for 
the pull-down assay. (C) Co-immunoprecipitation assay: 
Whole cell protein extracts from HEK293 cells transfected 
with plasmids expressing parafibromin-myc-his or menin-
myc-his alone or together with FLAG-actinin-2 or FLAG-
actinin-3 were immunoprecipitated with a rabbit anti-myc 
antibody. The immunoprecipitates were analyzed by western 
blotting (WB) with a mouse anti-myc (to detect parafibro-
min) or anti-FLAG (to detect actinin) antibody. Input panels 
show portions of protein extracts corresponding to 1/40th of 
the amount used for each immunoprecipitation (IP), probed 
with anti-myc or anti-FLAG antibody.
Table 2: Yeast Two-hybrid Interaction† of Parafibromin Fused to 
Gal4DBD with Full-length Proteins Fused to Gal4AD
Activation Domain Fusion β-Galactosidase Assay
1 Actinin-1 -
2 Actinin-2* ++
3 Actinin-3* +++
4 Actinin-4 -
5 α-actin -
6F H L - 1 -
7F H L - 2 + +
8F H L - 3 -
9F H L - 4 -
10 Desmin ++
11 β-catenin* +
†Yeast strain MaV203 that contains the Gal4-LacZ reporter or 
EGY48/pSH-18 (for β-catenin) that contains the LexA-LacZ reporter 
was transformed with plasmids expressing Gal4DBD- or LexA-DBD-
fusion proteins together with plasmids expressing Gal4AD-fusion 
proteins. Transformed yeast colonies selected in SD medium lacking 
Leu and Trp (Leu, Trp and Ura for EGY48/pSH-18) were scored for 
β-galactosidase activity in colony filter lift assays. Interaction is 
indicated by β-galactosidase activity level. -, +, ++, or +++ indicate no, 
low, medium or high levels of β-galactosidase activity, respectively. 
None of the Gal4AD fusions interacted with Gal4DBD alone or with 
Gal4DBD-p53 (aa 72–390 of mouse p53). The Gal4DBD-parafibromin 
did not interact with Gal4AD alone or Gal4AD-TAg (aa 87–708 of 
SV-40 T-antigen).
*Interaction was also positive with parafibromin fused to LexA-DBD 
(construct from [22]).Molecular Cancer 2008, 7:65 http://www.molecular-cancer.com/content/7/1/65
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Parafibromin and actinin interacting regions Figure 2
Parafibromin and actinin interacting regions. (A) Schematic of the 531 amino acid (aa) parafibromin protein. Striped 
regions are the 3 nuclear localization signals (aa 76–92, 125–139, and 393–409). The 2 black lines on top show the β-catenin 
interacting region (aa 218–263), and the Cdc73p homologous region (aa 343–531). Below are shown regions of parafibromin 
fused to the Gal4DBD that were tested for interaction with Gal4AD-actinin-3 by yeast two-hybrid assays as described in the 
footnote of Table 2. (B) Schematic of actinin-3 protein (901 amino acids). Following the N-terminal actin-binding region are 4 
striped areas corresponding to the 4 spectrin repeats: SR-1 (aa 288–398), SR-2 (aa 408–512), SR-3 (aa 523–634), and SR-4 (aa 
642–747). The two black areas near the C-terminus are the EF-hand domains (aa 764–793, and 800–828). Below are shown 
regions of actinin-3 fused to the Gal4AD that were tested for interaction with Gal4DBD-parafibromin by yeast two-hybrid 
assays as described in the footnote of Table 2. The dashed grey shaded area (aa 330–397) in the first actinin-3 construct corre-
sponds to the location of the truncated N-terminus (aa 323, 327, 329, 333, 340, 360, 370, 377, 381 and 390) of the 10 inde-
pendent actinin-2 clones, in-frame with the Gal4AD, isolated by yeast two-hybrid library screening. Also shown is the 
schematic of actinin-1 protein (892 amino acids) representing the two non-muscle actinins (actinin-1 and actinin-4) that do not 
interact with parafibromin. They show over 75% amino acid sequence identity with the muscle actinins (actinin-2 and actinin-3). 
Their domain composition and domain location is similar to the muscle actinins. However, the muscle actinins possess amino 
acid substitutions (not shown) in the EF hand domains that prevent calcium binding and render them insensitive to calcium. 
Calcium binding reduces the affinity of non-muscle actinins for F-actin [35]. Interaction is indicated by β-galactosidase activity 
level. -, +, ++, or +++ indicate no, low, medium or high levels of β-galactosidase activity, respectively. Activity level intermedi-
ate between 2 categories is indicated by a slash separating the 2 categories.Molecular Cancer 2008, 7:65 http://www.molecular-cancer.com/content/7/1/65
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[27]. Therefore, the effect of parafibromin on the actin
bundling property of actinins in vitro was analyzed. In the
actin sedimentation assay, F-actin bundles were found in
the pellet fraction when F-actin was mixed with actinin
alone or parafibromin alone, or actinin and parafibromin
together; F-actin bundles were not found in the pellet frac-
tion when F-actin was mixed with GST protein or buffer
alone (Figure 3A and Figure 3B) or with RPA2 (data not
shown). Thus, parafibromin did not inhibit the actin bun-
dling property of actinin. However, parafibromin was
itself capable of pelleting F-actin, indicating that parafi-
bromin possessed some actin bundling (or actin cross-
linking) activity.
Differentiation induced cytoplasmic localization of 
parafibromin with actinins
The specificity of the anti-parafibromin antibody GRAPE
was analyzed in HeLa cells by detection of endogenous
parafibromin or transfected parafibromin-myc-his. The
immunofluorescence patterns detected by GRAPE or anti-
myc antibody were identical, showing nuclear staining of
cells transfected with parafibromin-myc-his (Figure 4).
Also, nuclear staining representing endogenous parafibro-
min was specifically detected by GRAPE. HeLa cells trans-
fected with parafibromin-myc-his showed morphologic
changes associated with apoptosis (nuclear fragmentation
and nuclear condensation) similar to those observed in
cells transfected with a GFP-parafibromin construct [16].
Actinin-2 and actinin-3 are abundantly expressed in the
cytoplasmic compartment when muscle precursor cells
(myoblasts) are induced to differentiate into myotubes
[28]. Therefore, localization of endogenous parafibromin
and actinins was analyzed in the mouse myoblast cell line
C2C12 that was undifferentiated or differentiated into
myotubes. Parafibromin was predominantly nuclear in
undifferentiated proliferating C2C12 cells; interestingly,
in differentiated myotubes parafibromin was mainly
located in the cytoplasmic compartment with actinins
(Figure 5).
Localization of endogenous parafibromin with transfected 
actinin in the cytoplasm
The co-localization of actinin and parafibromin in the
cytoplasmic compartment in C2C12 cells stimulated to
form myotubes could be unrelated to parafibromin-
actinin interaction. Therefore, the ability of actinin to shift
parafibromin from its predominantly nuclear location
into the cytoplasm was analyzed by immunofluorescence
in HEK293 cells. Transfection of a plasmid expressing
actinin-2 in HEK293 cells caused accumulation of endog-
enous parafibromin in the cytoplasm (Figure 6). No
change in morphology of HEK293 cells was evident upon
co-localization of actinin and parafibromin in the cyto-
plasm.
Discussion
One of the functional associations of parafibromin is with
the PAF1 complex, involved in the regulation of transcrip-
tional initiation and elongation in yeast, and based upon
the presence of a C-terminal domain homologous to yeast
Cdc73p [10,19-21]. This function of parafibromin is also
connected to the Wnt signaling pathway by interaction
with β-catenin [22]. In this interaction, parafibromin pos-
sibly recruits the PAF1 complex to β-catenin responsive
genes thereby modulating the transcriptional output of β-
catenin. In reporter assays, β-catenin mediated transcrip-
tion could be regulated by Drosophila  parafibromin
(hyrax) but not by yeast Cdc73p [22]. In Drosophila with
mutant hyrax alleles, human or Drosophila parafibromin
could rescue the lethal phenotype [22]. The lethal pheno-
type of mutant hyrax alleles was not rescued by yeast
Cdc73p. The presence of the N-terminal 350 amino acid
Actin bundling/cross-linking by actinin and parafibromin Figure 3
Actin bundling/cross-linking by actinin and parafibro-
min. (A) GST-parafibromin, and parafibromin separated 
from GST after thrombin cleavage was analyzed by SDS-
PAGE and stained with Coomassie Blue. On the left are 
shown molecular weights of the protein standards in kilodal-
tons. Arrows show the bands corresponding to GST-parafi-
bromin (upper arrow for the panel on the left) and 
parafibromin (lower arrow for the panel on the right). (B) G-
actin was polymerized to F-actin. F-actin was incubated with 
rabbit skeletal muscle actinin, parafibromin (2 different 
preps) or GST (2 different preps) alone, or together as indi-
cated, and centrifuged at 10,000 g for 15 minutes to sediment 
higher order structures of F-actin (bundles and/or cross-
linked networks). The F-actin in the supernate (not bundled/
cross-linked) and pellet (F-actin bundles/networks) fraction 
was analyzed by SDS-PAGE and stained with Coomassie 
Blue. Lane 10 (buffer) contains F-actin that was sedimented 
without any added GST, actinin or parafibromin, and there-
fore corresponds to the background level of F-actin bundles/
networks in the pellet (similar background amount was also 
seen in the lane 6 and 7 marked GST). Increased actin, above 
background level, in the pellet fraction (lane 1, 2, 3, 4, 5, 8 
and 9) indicates F-actin bundling and/or cross-linking.Molecular Cancer 2008, 7:65 http://www.molecular-cancer.com/content/7/1/65
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region in human and Drosophila parafibromin that is not
found in yeast Cdc73p suggests that, in addition to its
Cdc73-associated function, parafibromin could possess
other activities and/or functional associations.
Using the yeast two-hybrid approach, we report interac-
tion of the N-terminus of parafibromin with muscle
actinins. Multiple (n = 10) independent clones of actinin-
2 were isolated in the yeast two-hybrid library screen, and
the interaction was verified by other in vitro and in vivo
methods suggesting a strong and significant interaction
between parafibromin and actinin-2. Actinins (molecular
mass ~100 kDa) are actin-binding proteins that are
expressed in both muscle and non-muscle cells, and that
cause bundling of actin filaments for cytoskeletal organi-
zation [29]. Actinins also serve to link the cytoskeleton,
membrane proteins, and signaling proteins [30,31]. There
are 4 alpha-actinins encoded by 4 different genes. The 4
proteins are highly homologous sharing 73–84% amino
acid sequence identity [32]. Actinin-1 and actinin-4 are
abundant in non-muscle cells, forming actin filament
bundles such as stress fibers. They are associated with cal-
cium dependent membrane attachment, and with cell-cell
and cell-matrix adherent junctions [33]. In muscle cells,
actinin-2 and actinin-3 are major structural components
of striated muscle where they anchor actin filaments [34].
Actinin-2 is expressed in all muscle cells, whereas actinin-
3 expression is limited to a subset of fast twitch skeletal
fibers. In our yeast two-hybrid assays, parafibromin selec-
tively interacted with the two muscle actinins (actinin-2
and actinin-3) but not at all with the non-muscle actinins
(Table 2).
Location of endogenous parafibromin and actinin in C2C12  myoblasts or C2C12 differentiated into myotubes Figure 5
Location of endogenous parafibromin and actinin in 
C2C12 myoblasts or C2C12 differentiated into myo-
tubes. C2C12 cells were analyzed by immunofluorescence 
with anti-parafibromin (GRAPE) antibody and anti-actinin 
antibody before (A, B, C) or after differentiation (D, E, F), 
and secondary antibody conjugated to Texas Red (to detect 
parafibromin) or fluorescein isothiocyanate (to detect 
actinin), followed by DAPI staining (A, D). Note that in panel 
E, along with myotubes there are some undifferentiated 
myoblasts that retain nuclear parafibromin staining (arrows). 
Magnification, 60× (A, B, C), or 10× (D, E, F).
Specificity of anti-parafibromin antibody (GRAPE) by immun- ofluorescence Figure 4
Specificity of anti-parafibromin antibody (GRAPE) by 
immunofluorescence. HeLa cells transfected with plasmid 
expressing parafibromin-myc-his (A, B, C, D) or untrans-
fected (E, F) were analyzed by immunofluorescence with pri-
mary antibodies that recognize the myc-tag (B) or 
parafibromin (D, F), and secondary antibody conjugated to 
Texas Red, followed by DAPI staining (A, C, E). Magnifica-
tion, 60×.Molecular Cancer 2008, 7:65 http://www.molecular-cancer.com/content/7/1/65
Page 7 of 11
(page number not for citation purposes)
Actinins are composed of three distinct domains. An N-
terminal actin-binding domain, a central rod-shaped
domain with 4 internal spectrin-like repeats required for
anti-parallel dimerization, and a C-terminal calmodulin-
like domain containing a pair of calcium-binding EF
hands [35] (Figure 2B). The EF-hands in non-muscle
actinins, actinin-1 and actinin-4, are functional (calcium
sensitive) whereas the EF-hands in muscle actinins,
actinin-2 and -3 are non-functional (calcium insensitive).
All the library clones of actinin-2 interacting with parafi-
bromin were truncated at the N-terminus thus lacking the
actin-binding domain and most of the first spectrin repeat
of actinins. Further deletion of the N-terminus including
the second spectrin repeat prevented interaction with
parafibromin. Similarly, actinin-3 lacking its C-terminal
EF-hand domains allowed interaction with parafibromin,
but further C-terminal deletion including the third and
fourth spectrin repeat (but retaining the first and second
spectrin repeat) impaired interaction with parafibromin.
Therefore, parafibromin likely interacts with the region of
actinin containing spectrin repeats 2, 3 and 4 (Figure 2B).
The region of highest variability among all actinins is in
spectrin repeats 3 and 4 (not shown in Figure 2B) [36].
This could potentially explain why parafibromin interacts
with muscle actinins and not with non-muscle actinins.
Deletion of N-terminal 112 amino acids of parafibromin
impaired actinin interaction. The N-terminal region of
parafibromin minus its C-terminal Cdc73p homologous
domain was sufficient for interaction with actinin (Figure
2A).
Actinins possess actin bundling and cross-linking activity
[26,27,35]. In low speed actin sedimentation assays
where actin filaments (F-actin) pellet only when they are
arranged in higher order structures by cross-linking and/
or bundling, just like actinin, to our surprise parafibromin
was also capable of pelleting F-actin, indicating that
parafibromin probably has inherent F-actin bundling or
cross-linking activity. Moreover, despite parafibromin's
predicted interaction with a part of the actinin dimeriza-
tion region, parafibromin did not displace or disrupt
actinin from F-actin bundles based on the observation
that presence of parafibromin and actinin together
appeared to slightly enhance the pelleting of F-actin (Fig-
ure 3B). This assay does not distinguish if the increased F-
actin in the pellet fraction upon incubation of F-actin with
actinin and parafibromin together was due to an increase
in the number of F-actin bundles, or due to thicker bun-
dles resulting from an increase in the number of F-actin
filaments in individual bundles, or due to increased cross-
linking. In yeast two-hybrid assays parafibromin did not
interact with actin (Table 2). Parafibromin sequence anal-
ysis did not reveal any regions with significant homology
to the several different actin-binding motifs that are found
in actin-binding proteins [37].
Skeletal muscle myoblasts (such as modeled by C2C12
cells) can be induced to differentiate in mitogen-poor
media to fuse and form multinucleate myotubes. This
myogenic program is coupled to loss of cell proliferation
and increase of differentiation. Actinins are important
cytoskeletal structural proteins and their expression in the
multinucleate myotubes increases upon induction of
myotube formation [28]. Parafibromin's accumulation in
the cytoplasm coincides with the inhibition of prolifera-
tion and with the activation of differentiation. The co-
localization of parafibromin and actinin in the cytoplasm
could be unrelated to their direct interaction. But the
changed compartmentalization in HEK293 cells of endog-
enous parafibromin to the cytoplasm upon actinin trans-
fection (Figure 6) indicates that the observation in C2C12
cells is likely related to parafibromin-actinin interaction.
Parafibromin-actinin interaction might be directly impor-
tant for mechanical strength and structure of the actin
Location of endogenous parafibromin in HEK293 cells trans- fected with actinin Figure 6
Location of endogenous parafibromin in HEK293 
cells transfected with actinin. HEK293 cells transfected 
with plasmid expressing FLAG-actinin-2 were analyzed by 
immunofluorescence with primary antibodies that recognize 
parafibromin (GRAPE) or the FLAG-tag (actinin-2), and sec-
ondary antibody conjugated to Texas Red (B, to detect 
endogenous parafibromin) or fluorescein isothiocyanate (C, 
to detect transfected actinin-2), followed by DAPI staining 
(A). Note that in untransfected cells parafibromin is nuclear 
but in the 3 cells over-expressing FLAG-actinin-2, parafibro-
min is in the cytoplasm. Merged Texas Red (parafibromin) 
and fluorescein isothiocyanate (actinin-2) signal is shown in 
panel D. Magnification, 60×.Molecular Cancer 2008, 7:65 http://www.molecular-cancer.com/content/7/1/65
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cytoskeleton, or the interaction could mediate other regu-
latory functions. Actin and actinin could play a role in reg-
ulating parafibromin levels in the nucleus for modulating
parafibromin's transcription associated functions. The
transcription associated tumor suppressor function of
parafibromin could require its migration from the nucleus
to cytoplasm as in C2C12 cells. Actin has been implicated
in regulating gene transcription through several mecha-
nisms, one of which is a direct role in controlling the
nucleo-cytoplasmic distribution of transcription factors
(Reviewed in [38]). Therefore, this interaction could be
important for regulating the activity, and sub-cellular
localization of parafibromin. Our observations in C2C12
cells also suggest other new aspects of parafibromin action
such as a possible role in organization of the cytoskeleton
and in myotube differentiation. We have investigated
parafibromin-actinin interaction in muscle cells. The
functional consequence of parafibromin-actinin interac-
tion in cells affected in HPT-JT – parathyroid cells, bone
cells, or renal cells – remains to be determined.
In C. elegans, RNAi against HRPT2 caused defects in the
proper formation of polar bodies, pronuclei and mitotic
nuclei indicating that HRPT2 is important for the proper
completion of both meiosis and mitosis [39]. The pheno-
type analysis also suggested that the HRPT2 product is
important for microtubule-based function in the early
embryo. Perhaps, this function of parafibromin is also
linked to its association with actinins.
Conclusion
Our study does not directly address parafibromin's partic-
ipation in the PAF-1 complex or the physiological func-
tion of parafibromin in the nucleus or cytoplasm, but the
observation that interaction with actinins (and actin fila-
ment bundling/cross-linking) likely occurs when parafi-
bromin accumulates in the cytoplasm suggests that a
biological activity of parafibromin might be controlled by
signals that promote its cytoplasmic accumulation. Fur-
ther studies to recognize such signals and their conse-
quences could provide insight into the functions of
parafibromin in normal physiology and in tumorigenesis.
Materials and methods
Antibodies
Anti-parafibromin rabbit polyclonal antibody GRAPE was
generated against a synthetic peptide (human parafibro-
min amino acid 262–299), and then affinity purified [16].
Mouse monoclonal anti-alpha-actinin clone BM-75.2 and
mouse anti-FLAG M2 antibodies were from Sigma; rabbit
anti-myc and mouse anti-myc antibodies were from
Upstate. Rabbit IgG, mouse IgG, and HRP-conjugated sec-
ondary antibodies were from Santa Cruz Biotechnologies.
Anti-rabbit secondary antibody conjugated to Texas Red
and anti-mouse secondary antibody conjugated to fluo-
rescein isothiocyanate were from Jackson ImmunoRe-
search Laboratories. Rabbit polyclonal affinity-purified
peptide antibodies against actinin-2 and against actinin-3
were a gift from Dr. Neal Epstein of NHLBI, NIH.
Mammalian cell culture and transfection
HEK293, HeLa, and C2C12 cell lines were obtained from
American Type Culture Collection and grown in complete
Dulbecco's modified Eagle's medium (DMEM containing
high glucose, 2 μM glutamine, 1× concentration of antibi-
otic-antimycotic mix, and 10% fetal bovine serum) at
37°C in a humidified incubator containing 5% CO2. For
differentiation of C2C12 myoblasts into myotubes, sub-
confluent cells were grown for 4–6 days in differentiation
medium (DMEM containing high glucose, 2 μM
glutamine, 1× concentration of antibiotic-antimycotic
mix, and 2% horse serum). Transient transfection was car-
ried out with Polyfect (Qiagen) as per the manufacturer.
Yeast two-hybrid assay
Yeast reporter strains for yeast-two-hybrid experiments
were Y190 (Clontech), MaV203 (Invitrogen), or EGY48
(kind gift from Dr, Erica Golemis, Wayne State Univer-
sity). Matchmaker two-hybrid system II and the Mamma-
lian Matchmaker two-hybrid assay kit were from
Clontech.
The coding region of HRPT2 was amplified from human
leukocyte marathon cDNA (Clontech) with primers con-
taining restriction enzyme sites using Turbo Pfu (Strata-
gene), and cloned into the Gal4 DNA-binding domain
(Gal4DBD)-fusion vector pAS2-1 in-frame with the
Gal4DBD. All primers and PCR conditions in this study
are available upon request.
pAS2-1-parafibromin was used as a bait to screen a yeast
two-hybrid human heart cDNA library in the Gal4-Activa-
tion Domain (AD)-fusion vector pACT-2 (Clontech) by
sequential transformation in Y190. The bait Gal4DBD-
parafibromin did not have any transcription-activating
property nor did it interact with Gal4AD alone or with
Gal4AD-T-antigen. Transformed yeast were grown in 50
large (150 mm) petri dishes of SD -Trp, -Leu, -His selec-
tion media containing 20 mM 3-Aminotriazole (3AT) to
control the leaky nature of the His+ phenotype. Colonies
positive for growth were restreaked and tested for the sec-
ond reporter LacZ (β-galactosidase (β-gal) activity) by col-
ony filter lift assay (yeast protocols handbook, Clontech).
Plasmids from colonies positive for growth in selection
media and positive for β-gal activity (blue), correspond-
ing to library plasmid expressing parafibromin interacting
proteins, were retrieved by using the yeast DNA isolation
system (Stratagene). These pACT-2 library plasmids were
retransformed into yeast competent cells (MaV203)
together with pAS2-1-parafibromin to confirm the pro-Molecular Cancer 2008, 7:65 http://www.molecular-cancer.com/content/7/1/65
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tein-protein interaction. None of the library positives
were self-activating nor did they interact with Gal4DBD-
p53 or Gal4DBD alone. Plasmids that still were positive
for parafibromin interaction after this testing were
sequenced with vector primers at both ends of the insert.
Other constructs in the pAS2-1 or pACT-2 were generated
by cloning in-frame inserts. Full-length coding region of
actinin-1, actinin-2, actinin-3, actinin-4, desmin, FHL-1,
FHL2, FHL-3, FHL-4, and α-actin was amplified using
marathon cDNA (Clontech) from human skeletal muscle
(actinin-2, actinin-3, desmin, FHL-1, FHL2, FHL-3, and α-
actin), human brain (actinin-1 and actinin-4), or mouse
testis (FHL-4), with primers containing restriction enzyme
sites using Turbo Pfu (Stratagene), and cloned into pACT-
2. Inserts containing various deletions from the N- and C-
terminus of parafibromin or actinin-3 were generated by
PCR amplification using appropriate primers, with pAS2-
1-parafibromin or pACT-2-actinin-3 as the template, and
cloned into pAS2-1 or pACT-2, respectively. For testing
interaction of parafibromin deletion constructs, actnin-3
was used because the interaction of full-length actinin-3
with parafibromin was similar but slightly stronger than
with full-length actinin-2. The LexA-DBD-parafibromin
construct pCM031 and the Gal4AD-β-catenin construct
pRH95 were provided by Dr. Christian Mosimann, Uni-
versity of Zurich [22].
Interaction of fusion-proteins expressed by the pAS2-1
and pACT-2 constructs were tested by transforming into
yeast competent cells (MaV203). Yeast colonies growing
on plates containing SD -Trp, -Leu selection media were
tested for β-gal activity by colony filter lift assay. None of
the pACT-2 constructs were self-activating nor did they
interact with Gal4DBD-p53 or Gal4DBD alone. The inter-
action of parafibromin in LexA-DBD vector with β-catenin
in Gal4-AD vector was tested in the yeast strain EGY48
using the LexA reporter pSH18-34 and SD -Trp, -Leu, -Ura
selection media.
To verify the expression of fusion proteins in yeast, pro-
tein extracts were analyzed by western blot [40].
GST pull-down assay
The full-length coding regions of actinin-2, actinin-3,
desmin or FHL2 were sub-cloned from the yeast two-
hybrid vector pACT-2 into the GST-fusion vector pGEX5X-
2 (Amersham-Pharmacia). The coding region of parafi-
bromin was amplified from leukocyte marathon cDNA
and cloned into the myc-tag fusion vector pcDNA3.1(-)-
myc-his-A (Invitrogen) in-frame with a downstream myc-
his-tag. In order to generate an in-frame fusion of parafi-
bromin at the C-terminus with the myc-his tag, the parafi-
bromin stop codon was changed from TGA to AGA in the
reverse primer.
GST or GST-fusion proteins (GST-actinin-2, GST-actinin-
3, GST-desmin or GST-FHL2) were expressed in bacteria
in the E. coli BL21-PRIL strain (Stratagene), and purified
on glutathione sepharose beads (Amersham-Pharmacia)
as described [40]. Similar amounts of GST alone, or GST-
fusion proteins coupled to glutathione sepharose beads
were incubated overnight at 4°C with whole cell protein
extracts from HEK293 cells transfected with a plasmid
expressing parafibromin-myc-his. The beads were washed
thoroughly 5 times with the lysis buffer-1 (TBS containing
0.1% Triton X-100 and 1 mM DTT) that was used for pre-
paring protein extracts, and resuspended in protein load-
ing buffer. The bound parafibromin was detected by
western blot with an anti-myc antibody.
Co-immunoprecipitation
The full-length coding region of actinin-2 and actinin-3
was sub-cloned from the yeast two-hybrid vector pACT-2
into the FLAG-fusion vector pCMVtag2C (Stratagene).
The plasmid construct expressing parafibromin-myc-his
was described above, and the menin-myc-his construct
was previously described [41]. Before their use in co-
immunoprecipitation (Co-IP) experiments, the FLAG-
actinin-2, FLAG-actinin-3, and parafibromin-myc-his
expression was verified by transfecting HEK293 cells and
analyzing whole cell protein extracts by western blot using
specific antibodies (data not shown).
HEK293 cells were transfected with plasmids expressing
FLAG-actinin-2 or FLAG-actinin-3 together with plasmids
expressing parafibromin-myc-his or menin-myc-his.
Whole cell protein extracts were prepared 48 h after trans-
fection in lysis buffer-2 (20 mM Tris pH 8.0, 150 mM
NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, and 0.1%
deoxycholate). Protein extracts were used for immunopre-
cipitation as described with 4 μg of rabbit anti-myc anti-
body [42]. Actinin and parafibromin were detected by
western blot with anti- FLAG or mouse anti-myc antibod-
ies, respectively.
Actin sedimentation assay
The full-length coding region of parafibromin was sub-
cloned from the yeast two-hybrid vector pAS2-1 into the
GST-fusion vector pGEXIIT (Amersham-Pharmacia). The
plasmid construct expressing GST-RPA2 was previously
described [42]. GST, GST-parafibromin, or GST-RPA2 was
expressed in bacteria in the E. coli BL21-PRIL strain (Strat-
agene) and purified on glutathione sepharose beads
(Amersham-Pharmacia) as described [40]. GST-parafibro-
min or GST-RPA2 conjugated to glutathione sepharose
beads was incubated in thrombin cleavage buffer (20 mM
Tris pH 7.5, 150 mM NaCl, 2.5 mM CaCl2, and 1 mM
DTT) with 10 U of thrombin (Sigma) per mg of GST-
fusion protein to remove the GST tag. Thrombin was inac-
tivated by adding a protease inhibitor cocktail (Roche Bio-Molecular Cancer 2008, 7:65 http://www.molecular-cancer.com/content/7/1/65
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chemicals) and 1 mM PMSF. The supernate containing
parafibromin or RPA2, after thrombin cleavage, was
passed through a benzamidine-sepharose column to
remove the thrombin. The flowthrough was concentrated
with an Amicon-50 (parafibromin) or an Amicon-10
(RPA2) concentrator. To obtain GST protein, glutathione
sepharose beads loaded with GST were eluted with 50 mM
Tris-HCl (pH 8) containing 10 mM reduced glutathione.
To maintain similar treatment conditions GST was also
incubated with thrombin, then with protease inhibitors,
passed through a benzamidine-sepharose column, and
concentrated with an Amicon-10 concentrator.
Low speed actin sedimentation assays used the Actin
binding protein Biochem kit as per the manufacturer
(Cytoskeleton). Briefly, rabbit skeletal muscle G-actin
(monomeric globular actin) was polymerized to F-actin
(polymerized filamentous actin). F-actin (36 μg) was
mixed with actinin (10 μg) or parafibromin (4 μg) or GST
(4 μg) or RPA2 (4 μg) or with thrombin cleavage buffer
alone, or with actinin and parafibromin, or with actinin
and GST, or with actinin and RPA2, and centrifuged at
10,000 g at room temperature for 15 minutes. The super-
nate was removed carefully and mixed with 12 μl of 5×
protein loading buffer (supernatant fraction). The pellet
was resuspended in 60 μl of 1× protein loading buffer
(pellet fraction). 20 μl of the pellet fraction and 20 μl of
the supernatant fraction were analyzed by SDS-PAGE, and
the proteins were detected by Coomassie Blue.
Immunofluorescence
Cells (HeLa, HEK293 or C2C12) were seeded on two-well
chamber slides in complete DMEM and incubated over-
night. To obtain differentiated C2C12 myotubes, sub-
confluent cells were grown in differentiation medium for
4–6 days. Cells on chamber slides were fixed in PBS con-
taining 4% paraformaldehyde for 20–30 minutes at room
temperature and permeabilized with PBS containing
0.5% Triton X-100 for 5 minutes at room temperature.
Conventional immunofluorescence was carried out as
described [42]. Microscopy and photomicrography was
performed with an epifluorescence microscope (Zeiss).
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